Therapy Switching, Add-on, and Discontinuation in Patients With Osteoarthritis in the United Kingdom

Sep-11

AUTHORS : Prof Douglas Leslie, Penn State College of Medicine, A210 Public Health Sciences, Hershey, PA 17033 US / Center for Applied Studies in Health Economics, Division of Health Services and Behavioral Research – Email: dll35@psu.edu – Profile: https://cashe.psu.edu/faculty/douglas-leslie/ AND https://pennstate.pure.elsevier.com/en/persons/douglas-leslie – Contact is Alesia Sadosky, Pfizer, but she has now retired

JOURNAL : Osteoarthritis and Cartilage

REFERENCE: 19(S1):S230

DOI : 10.1016/S1063-4584(11)60524-4

Therapy Switching, Add-on, and Discontinuation in Patients With Osteoarthritis in the United Kingdom

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study